The effects of pyrrolizidine alkaloids and d-tubocurarine on mitochondrial metabolism.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002273:Carcinogens; D006859:Hydrogen / Q000378:metabolism; D008274:Magnesium / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000037:antagonists & inhibitors; D010085:Oxidative Phosphorylation / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D051381:Rats; D014403:Tubocurarine / Q000494:pharmacology*
D000470:Alkaloids; D002273:Carcinogens; D009243:NAD; D006859:Hydrogen; D008274:Magnesium; D011188:Potassium; D014403:Tubocurarine